Cited by 19SARS-CoV-2 and COVID-19 ResearchRNA Interference and Gene DeliveryAdvanced Drug Delivery Systems

The evaluation of novel oral vaccines based on self-amplifying RNA lipid nanparticles (saRNA LNPs), saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum to neutralize SARS-CoV-2 variants alpha and delta

Open access
Keikha, Reza, Hashemi-Shahri, Seyed Mohammad, Jebali, Ali·2021·Scientific Reports

Abstract

The aim of this study was to present and evaluate novel oral vaccines, based on self-amplifying RNA lipid nanparticles (saRNA LNPs), saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum, to neutralize severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) variants alpha and delta. After invitro evaluation of the oral vaccines on HEK293T/17 cells, we found that saRNA LNPs, saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum could express S-protein at both mRNA and protein levels. In the next step, BALB/c mice were orally vaccinated with saRNA LNPs, saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum at weeks 1 and 3. Importantly, a high titer of IgG and IgA was observed by all of them, sharply in week 6 (P < 0.05). In all study groups, their ratio of IgG2a/IgG1 was upper 1, indicating Th1-biased responses. Wild-type viral neutralization assay showed that the secreted antibodies in vaccinated mice and recovered COVID-19 patients could neutralize SARS-COV-2 variants alpha and delta. After oral administration of oral vaccines, biodistribution assay was done. It was found that all of them had the same biodistribution pattern. The highest concentration of S-protein was seen in the small intestine, followed by the large intestine and liver.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-00830-5

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 36 · Cited by 19

Research works printed but not linked: 1

  1. [16]Abeysundara, A. T., Aponso, M. & De Silva, G. A review on edible vaccines: A novel approach to oral immunization as a replacement of conventional vaccines.

Authors
Keikha, R., Hashemi-Shahri, S. M., & Jebali, A.
Affiliations
  • Zahedan University of Medical Sciences (IR)
  • Islamic Azad University, Tehran (IR)
Corresponding author
Jebali, Ali
Venue
Scientific Reports
Published
2021-10-29
Volume
11
Issue
1
Pages
21308-21308
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3210210298
Cited by
19
References
36
Citations by year
2026: 3 · 2025: 4 · 2024: 1 · 2023: 7 · 2022: 4
FWCI
0.95
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Universidad de Navarra
  • Zahedan University of Medical Sciences
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
oral vaccine, self-amplifying RNA, lipid nanoparticles, Lactobacillus plantarum, SARS-CoV-2, COVID-19 pandemic, S protein, neutralizing antibodies, IgA, IgG2a/IgG1 ratio, Th1 response, Alpha variant, Delta variant, small intestine
MeSH terms
COVID-19, SARS-CoV-2, COVID-19 Vaccines, mRNA Vaccines, Administration, Oral, Adult, Animals, Antibodies, Viral, Female, Humans, Immunoglobulin A, Immunoglobulin G, Intestine, Small, Lipids, Male, Mice, Inbred BALB C, Middle Aged, Neutralization Tests, RNA, Messenger, Tissue Distribution, Transfection, Vaccination, Vaccines, Synthetic, Models, Animal, Lactiplantibacillus plantarum, Mice, Nanoparticles, Antibodies, Neutralizing, HEK293 Cells, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review